Yvonne Greenstreet
Chief Executive Officer at Alnylam Pharmaceuticals · 83 reported transactions in 1 company · latest trade Feb 13, 2026
Their trades
Sold | Feb 13, 2026 | Feb 13, 2026 close $314.40 → Oct 26, 2026 close $227.66. S&P 500 +12.3% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. | ||
Sold | Jan 12, 2026 | Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days. |
$2.16M
Feb 13, 2026 close $314.40 → Oct 26, 2026 close $227.66. S&P 500 +12.3% over the same days.
$35.5K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$44.3K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$33K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$7.8K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$43.8K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$93.5K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.
$215.3K
Jan 12, 2026 close $370.91 → Oct 26, 2026 close $227.66. S&P 500 +10.1% over the same days.